Terapia Combinada com Anticorpos Bispecíficos e Bloqueio de PD-1 Aumenta a Potência Antitumoral das Células T

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Bispecific antibodies with natural architecture produced by co-culture of bacteria expressing two distinct half-antibodies2013 · 200 citations
2. 2A novel bispecific antibody format enables simultaneous bivalent and monovalent co-engagement of distinct target antigens2011 · 103 citations
3. 3BiTEs: bispecific antibody constructs with unique anti-tumor activity2005 · 264 citations
4. 4PD-L1 Expression in Triple-Negative Breast Cancer2014 · 1,407 citations
5. 5Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia2013 · 3,497 citations